BioCentury
ARTICLE | Financial News

Akebia completes IPO

March 24, 2014 7:00 AM UTC

Akebia Therapeutics Inc. (NASDAQ:AKBA), Cambridge, Mass. Business: Hematology, Cardiovascular Date completed: 3/20/14 Type: IPO Raised: $100 million Shares: 5.9 million Price: $17 Shares after offerin...